氯喹
羟基氯喹
药物重新定位
疟疾
重新调整用途
自噬
药品
药理学
病毒学
医学
2019年冠状病毒病(COVID-19)
生物
免疫学
疾病
传染病(医学专业)
内科学
细胞凋亡
生态学
生物化学
作者
Wenmin Zhou,Hui Wang,Yuqi Yang,Zhe‐Sheng Chen,Chang Zou,Jianye Zhang
标识
DOI:10.1016/j.drudis.2020.09.010
摘要
Quinoline (QN) derivatives are often used for the prophylaxis and treatment of malaria. Chloroquine (CQ), a protonated, weakly basic drug, exerts its antimalarial effect mainly by increasing pH and accumulating in the food vacuole of the parasites. Repurposing CQ is an emerging strategy for new indications. Given the inhibition of autophagy and its immunomodulatory action, CQ shows positive efficacy against cancer and viral diseases, including Coronavirus 2019 (COVID-19). Here, we review the underlying mechanisms behind the antimalarial, anticancer and antiviral effects of CQ. We also discuss the clinical evidence for the use of CQ and hydroxychloroquine (HCQ) against COVID-19.
科研通智能强力驱动
Strongly Powered by AbleSci AI